Skip to main content
Start triage

Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Need urgent help? Start triage first, then route to emergency care.

Start symptom intake Emergency vets near you

Meds A-Z

Bedinvetmab

Detailed information about Bedinvetmab

Official label facts Owner quick guide first Marketing clearly labeled
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Veterinary professional?

Showing simplified owner view. Switch to Vet View for full technical detail.

Add to My Pet's Meds

Choose a pet, confirm current or past, and optionally add reminder notes.

Sign in to save this medication to your pet profile.

Sign in to continue

Reviewed / Updated / Sources

Reviewed: Not available

Updated: February 12, 2026, 10:44 PM UTC

Sources:

Pet Owner Quick Guide

Start here first for the simple next-step summary.

Used for:

For the control of pain associated with osteoarthritis in dogs.

What to watch for:

  • Not himself/herself (1 reports)
  • Neurological signs NOS (1 reports)
  • Localised pain NOS (1 reports)

When to call the vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
  • Facial swelling or hives.
  • Blood in vomit or stool.

What to ask your vet today:

  • Is this medicine the right fit for my pet’s current symptoms?
  • Which warning signs mean I should call back right away?
  • How should I handle missed doses or refusal to take the medicine?
Safety & side effects

What to watch:

  • Not himself/herself
  • Neurological signs NOS
  • Localised pain NOS

Most reported reactions:

  • Not himself/herself (1 reports)
  • Neurological signs NOS (1 reports)
  • Localised pain NOS (1 reports)

When to call your vet:

  • Repeated vomiting or diarrhea.
  • Severe lethargy (hard to wake, very low energy).
  • Collapse or fainting.
  • Trouble breathing.
Talk to a Vet / Find a Vet Near You Start Symptom Intake

Data freshness: source data appears current.

Latest refresh: Mar 21, 2026, 10:02 a.m.

Data freshness
  • Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
  • Animal Drugs @ FDA: Source FDA | Refreshed Mar 21, 2026, 10:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Mar 21, 2026, 10:01 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Mar 21, 2026, 10:02 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Feb 17, 2026, 11:06 AM UTC
Image coming soon
Bedinvetmab

Bedinvetmab

Drug type: Generic ingredient • Branded profile • FDA branded products available

Species: Both

Manufacturer: Not available (source)

Quick Facts

Official label facts first, then secondary summaries. Marketing content is separated below.

Species: Both
Manufacturer: Not available
Form: Injectable Solution
Identifiers:
NADA: 141562 NDC Package: 54771-2772-1 NDC Package: 54771-2772-2 NDC Package: 54771-2778-1 NDC Package: 54771-2778-2 NDC Package: 54771-2779-1 NDC Package: 54771-2779-2 NDC Package: 54771-2780-1 NDC Package: 54771-2780-2 NDC Package: 54771-2781-1 NDC Package: 54771-2781-2 NDC Product: 54771
Source metadata:

Adverse Reactions

Snapshot first, detailed rows second. This section summarizes signal data and is not a diagnosis.

Tap or hover a reaction to see what it means in plain language.

Tracked signals
32
Reported cases
32
Serious reports
6
Species represented
2
Grouped by Body System
Skin & allergy (1) · Itching Neurologic (2) · Tiredness (lethargy), Neurological signs NOS Other (29) · Pain NOS, Other abnormal test result NOS, Oral mass
Most Reported Reactions
Reaction Body system Cases Species Serious cases
Other 1 Dog 1
Neurologic 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Other 1 Dog 1
Neurologic 1 Cat 0
Other 1 Dog 0

Species coverage: Dog (25) Cat (7)

View detailed reaction table
Reaction Body system Species Seriousness Frequency Reports
Neurologic Cat Non-serious - 1
Other Dog Non-serious - 1
Other Cat Non-serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Neurologic Dog Serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Skin & allergy Cat Non-serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Cat Non-serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Other Dog Serious - 1
Other Dog Non-serious - 1
Other Cat Non-serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Other Dog Non-serious - 1
Other Cat Non-serious - 1
Other Dog Non-serious - 1
Other Cat Non-serious - 1
Source metadata:

Documents

Owner handouts and official technical documents are grouped for faster access.

Owner handouts (0)
  • No owner handouts linked yet.
Official label / PI (1)
SPL (1)
  • Librela™ · SPL
    https://animaldrugsatfda.fda.gov/adafda/app/search/public/spl/file/14131/Librela%E2%84%A2
FOI (1)
Source metadata:
Veterinary reference (advanced)

Canonical medication sections are above. This legacy block remains available for deeper cross-reference without cluttering the primary workflow.

At a Glance

Quick facts and links to official labeling and safety signals.

Data freshness
  • Medication catalog: Source Roxee | Refreshed Feb 12, 2026, 10:44 PM UTC
  • Animal Drugs @ FDA: Source FDA | Refreshed Mar 21, 2026, 10:00 AM UTC
    Applications/products are imported from FDA export data.
  • Animal Drugs @ FDA previews: Source FDA | Refreshed Feb 9, 2026, 3:05 AM UTC
    Label highlights/doc links are fetched from FDA preview endpoints.
  • Animal Drug Product Listing Directory (NDC): Source FDA | Refreshed Mar 21, 2026, 10:01 AM UTC
    Package/product NDCs from FDA’s electronic listing directory (XLS).
  • openFDA reaction terms: Source FDA openFDA | Refreshed Mar 21, 2026, 10:02 AM UTC
  • openFDA case summaries: Source FDA openFDA | Refreshed Feb 17, 2026, 11:06 AM UTC
Official (FDA)
Identity: Generic ingredient • FDA branded products available
Official FDA brands: Librela™
Case-reported brands (openFDA): MSK
Catalog species: Both • FDA-labeled species: Dog
Rx/OTC: RX
Form/route: Injectable Solution • Subcutaneous
Applications: NADA 141-562
Documents: 2 (FOI: 1) • SPL: 1 • Label highlights • Official documents
Safety (openFDA)
Top reactions: Dog 25 • Cat 8 • View
Case summaries: 13 (showing 8) • View
openFDA reports are unverified and do not prove causation.
Explore
Linked using: Fda_Label (0.95), Fda_Label (0.95), Fda_Label (0.95)
Diagnosis Codes
ICD10_CM: M19.90
Unspecified osteoarthritis, unspecified site

Counseling and Monitoring Highlights

Global Pet owner/Vet mode is controlled in the header. This section avoids duplicate in-page persona tabs.

Top reaction signals
Not himself/herself (1) Neurological signs NOS (1) Localised pain NOS (1) Inappropriate urination (1) Hind limb paresis (1) Elevated renal parameters (1) Tiredness (lethargy) (1) Pain NOS (1)

Identifiers & Packages

Normalized identifiers (NDC/NADA/ANADA) and package metadata from regulator listings.

Identifiers
NADA: 141562 NDC Package: 54771-2772-1 NDC Package: 54771-2772-2 NDC Package: 54771-2778-1 NDC Package: 54771-2778-2 NDC Package: 54771-2779-1 NDC Package: 54771-2779-2 NDC Package: 54771-2780-1 NDC Package: 54771-2780-2 NDC Package: 54771-2781-1 NDC Package: 54771-2781-2 NDC Product: 54771
Package NDC Product NDC Form / Route Status
54771-2772-1 54771 -
54771-2772-2 54771 -
54771-2778-1 54771 -
54771-2778-2 54771 -
54771-2779-1 54771 -
54771-2779-2 54771 -
54771-2780-1 54771 -
54771-2780-2 54771 -
54771-2781-1 54771 -
54771-2781-2 54771 -

Enriched Documents

Documents are tiered by source trust: Official, Clinical, Manufacturer, Marketing.

Data Sources & Change Log

Every non-trivial field is expected to include provenance and update timestamps.

Official 4 Clinical 0 Manufacturer 0 Marketing 0
Current Field Facts
  • side_effects: Top reported reactions (openFDA): Death by euthanasia, Lethargy (see also Central nervous system depression in Neurological), Polydipsia, Ataxia, Vomiting, Pol… (Official, 2026-02-12)
  • usage: For the control of pain associated with osteoarthritis in dogs. (Official, 2026-02-12)
Recent Revisions
  • side_effects updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields
  • usage updated 2026-02-12 22:44 by etl_backfill • Backfilled from existing medication fields

FDA Products & Applications (Animal Drugs @ FDA)

Official sponsor/proprietary-name/application-status records linked by active ingredient.

Product Sponsor Application Status Published
Librela™
RX
Bedinvetmab
Injectable Solution • Subcutaneous
Label highlights
Official documents
Zoetis Inc. NADA 141-562 Approved Feb 19, 2025

Data source: FDA Animal Drugs @ FDA (public search export).

What It's For (FDA Label Highlights)

Extracted from FDA Animal Drugs @ FDA product labeling. Always confirm details with your veterinarian.

Species: Dog, No Use Class Stated Or Implied
Composition / specifications
5, 10, 15, 20, and 30 mg bedinvetmab/mL in sterile solution
Dogs
Indication

For the control of pain associated with osteoarthritis in dogs.

Dosage

Administer 0.23 mg/pound (0.5 mg/kilogram) body weight monthly by subcutaneous injection.

Limitations

FDA page: Open in Animal Drugs @ FDA

Official Documents (FDA)

Direct links to FDA-hosted PDFs and SPL packages (when available).

Documents
SPL Packages

FDA page: Open in Animal Drugs @ FDA

Usage

For the control of pain associated with osteoarthritis in dogs.

Source: FDA Animal Drugs @ FDA • Reference

Top Reported Reactions (openFDA)

De-duplicated reaction terms grouped by body system from FDA openFDA reports (not verified; does not prove causation).

Skin & allergy
Itching (1) • Cat

Showing top 5 for Skin & allergy.

Neurologic
Tiredness (1) • Cat Neurological signs NOS (1) • Dog

Showing top 5 for Neurologic.

Other
Pain NOS (1) • Dog Other abnormal test result NOS (1) • Cat Oral mass (1) • Dog Oral bleeding (1) • Dog Not himself/herself (1) • Dog
Show more (24)
Not eating (1) • Dog Neutrophilia (1) • Dog Muscle atrophy (1) • Dog Monocytosis (1) • Dog Localised pain NOS (1) • Dog Listless (1) • Dog Inappropriate urination (1) • Dog Horner's syndrome (1) • Dog Hind limb paresis (1) • Dog Hepatomegaly (1) • Dog General pain (1) • Cat Fever (1) • Dog Falling (1) • Dog Eosinopenia (1) • Dog Enlarged lymph node (1) • Dog Elevated renal parameters (1) • Dog Elevated globulins (1) • Dog Elevated alanine aminotransferase (1) • Cat Difficulty standing (1) • Dog Decreased drinking (1) • Dog Blood loss NOS (1) • Dog Accidental exposure (1) • Cat Abnormal radiograph finding (1) • Dog Abdominal discomfort (1) • Cat

Showing top 5 for Other.

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Adverse Event Case Summaries (openFDA)

These are individual FDA adverse event reports. They are unverified and do not prove the medication caused the reaction.

Dog, Retriever - Golden, Male, 15 year, 41.64 kilogram • Drug: MSK, Subcutaneous, Dose: 30 Milligram per animal • Reactions: Blood loss NOS, Oral mass, Enlarged lymph node, Oral bleeding • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-055805
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 15.00 Year
  • Weight: 41.640 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Dose: 30 Milligram per animal
Reactions Reported:
Blood loss NOS Oral mass Enlarged lymph node Oral bleeding
Outcomes: Ongoing

Dog, Dog (unknown), Male, 14 year, 33.566 kilogram • Drug: MSK, Subcutaneous, Dose: 20 Milligram per animal • Reactions: Hind limb paresis • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-055509
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 14.00 Year
  • Weight: 33.566 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Dose: 20 Milligram per animal
Reactions Reported:
Hind limb paresis
Outcomes: Ongoing

Dog, Retriever - Labrador, Male, 12 year, 34.292 kilogram • Drug: MSK, Subcutaneous, Dose: 20 Milligram per animal • Reactions: Horner's syndrome • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-055778
  • Serious AE: No
  • Treated For AE: No
  • Sex: Male
  • Age: 12.00 Year
  • Weight: 34.292 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Dose: 20 Milligram per animal
Reactions Reported:
Horner's syndrome
Outcomes: Ongoing

Dog, Mastiff (unspecified), Male, 8 year, 63.503 kilogram • Drug: MSK, Solution, Subcutaneous, Dose: 40 Milligram per animal, Frequency: 1 per month • Reactions: Elevated renal parameters • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-055098
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 8.00 Year
  • Weight: 63.503 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Solution
  • Dose: 40 Milligram per animal
  • Frequency: 1 per month
Reactions Reported:
Elevated renal parameters
Outcomes: Ongoing

Dog, ['Terrier (unspecified)', 'Dog (unknown)'], Male, 12 year • Drug: MSK, Solution, Subcutaneous • Reactions: Seizure NOS, Panting, Polydipsia, Not himself/herself, Pain NOS… • Outcome: Outcome Unknown

  • Report ID: USA-USFDACVM-2025-US-055277
  • Serious AE: Yes
  • Treated For AE: No
  • Sex: Male
  • Age: 12.00 Year
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Form: Solution
Reactions Reported:
Seizure NOS Panting Polydipsia Not himself/herself Pain NOS Vocalisation Neurological signs NOS
Outcomes: Outcome Unknown

Dog, ['Retriever - Labrador', 'Dog (unknown)'], Male, 14 year, 15.876 kilogram • Drug: MSK, Unknown, Dose: 10 Milligram per animal • Reactions: Seizure NOS, Inappropriate urination, Walking difficulty, Urinary incontinence, Swelling NOS… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-056004
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 14.00 Year
  • Weight: 15.876 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
  • Dose: 10 Milligram per animal
Reactions Reported:
Seizure NOS Inappropriate urination Walking difficulty Urinary incontinence Swelling NOS Unable to walk
Outcomes: Ongoing

Dog, ['Dachshund - Standard Long-haired', 'Dog (unknown)'], Male, 12 year, 8.936 kilogram • Drug: MSK, Subcutaneous, Dose: 5 Milligram per animal • Reactions: Fever, Panting, Swollen limb, Localised pain NOS, Paralysis NOS • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-055637
  • Serious AE: Yes
  • Treated For AE: Yes
  • Sex: Male
  • Age: 12.00 Year
  • Weight: 8.936 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Subcutaneous
  • Dose: 5 Milligram per animal
Reactions Reported:
Fever Panting Swollen limb Localised pain NOS Paralysis NOS
Outcomes: Ongoing

Dog, Shepherd Dog - German, Male, 5.8 year, 40.82 kilogram • Drug: MSK, Unknown • Reactions: Sneezing, Listless, Not eating, Reduced responses, Difficulty standing… • Outcome: Ongoing

  • Report ID: USA-USFDACVM-2025-US-055636
  • Serious AE: No
  • Treated For AE: Yes
  • Sex: Male
  • Age: 5.80 Year
  • Weight: 40.820 Kilogram
  • Case-reported brand: MSK
  • Case-reported manufacturer: MSK
  • Route: Unknown
Reactions Reported:
Sneezing Listless Not eating Reduced responses Difficulty standing Falling Polyuria Decreased drinking Fever Tachycardia Tachypnoea Weight loss Stress leukogram Neutrophilia Monocytosis Eosinopenia Elevated globulins Abnormal radiograph finding Hepatomegaly Proprioception deficit Muscle atrophy Pain NOS
Outcomes: Ongoing

Data source: FDA openFDA Animal & Veterinary adverse event reports.

Overdose Information

No approved overdose-management text is linked yet. If overdose is suspected, contact a veterinarian or emergency clinic immediately.

Storage & Handling

No approved storage guidance is linked yet for this ingredient. Use manufacturer packaging and veterinary guidance for handling/storage.

Share Your Thoughts

Let others know your experience or advice regarding this medication.

This medication has not been reviewed by a veterinarian yet.